Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children

PLoS One. 2013 Jun 25;8(6):e66771. doi: 10.1371/journal.pone.0066771. Print 2013.

Abstract

Background: Changes in the epidemiological characteristics of measles since 2007 appeared in the Jiangsu province. Although the reported coverage with two doses of measles vaccine was greater than 95% in most regions of the province, measles incidence remained high across the whole province. Cross-sectional serological surveys of measles antibodies in the Jiangsu province of China were conducted from 2008 to 2010 to assess and track population immunity.

Methods: Measles-specific IgG levels were measured in serum samples using ELISA. GMTs and seroprevalence with 95% CIs were calculated by region, gender, and age. ANOVA and χ(2) tests were used to test for statistically significant differences between groups for GMT levels and seroprevalence, respectively.

Results: Seroprevalence showed a significantly increasing trend annually (CMH χ(2) = 40.32, p<0.0001). Although the seroprevalence among children aged 2-15 years was consistently over 95%, vaccine-induced measles antibodies may wane over time. Measles seropositivity in the Jiangsu province was 91.7% (95% CI: 90.1-93.2%) in 2010. Among adults aged 15 to 29-year-olds, the seropositivity rate was 88.4% (95% CI: 82.7-92.8%).

Conclusions: Vaccination strategies may need to be adjusted depending on the individual age and regions, particularly individuals between the ages of 8 months-14 years old and 20-29 years old. Additional SIAs are likely required to eliminate measles in China.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Child
  • Child, Preschool
  • China / epidemiology
  • Cross-Sectional Studies
  • Data Collection
  • Female
  • Geography
  • Humans
  • Infant
  • Male
  • Measles Vaccine / immunology*
  • Measles virus / immunology*
  • Measles virus / physiology
  • Middle Aged
  • Sex Distribution
  • Viral Load
  • Young Adult

Substances

  • Antibodies, Viral
  • Measles Vaccine

Grants and funding

The authors have no support or funding to report.